Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates
Open Access
- 30 September 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (1) , 73-75
- https://doi.org/10.1016/j.diagmicrobio.2004.04.011
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- In vitro activity of BAL9141 against clinical isolates of gram-negative bacteriaDiagnostic Microbiology and Infectious Disease, 2004
- Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococciClinical Microbiology & Infection, 2003
- Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical CenterJournal of Antimicrobial Chemotherapy, 2003
- In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococciJournal of Antimicrobial Chemotherapy, 2002
- Eagle-Type Methicillin Resistance: New Phenotype of High Methicillin Resistance under mec Regulator Gene ControlAntimicrobial Agents and Chemotherapy, 2001
- In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 2001
- Basic mechanisms of bacterial tolerance of antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- THE RATE OF BACTERICIDAL ACTION OF PENICILLIN IN VITRO AS A FUNCTION OF ITS CONCENTRATION, AND ITS PARADOXICALLY REDUCED ACTIVITY AT HIGH CONCENTRATIONS AGAINST CERTAIN ORGANISMSThe Journal of Experimental Medicine, 1948